Rock Creek Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2016. The company has reported that for the first quarter ended March 31, 2016 loss per share was $0.22, compared to $0.04 loss per share, for the same quarter ended March 31, 2015. Operating loss from continuing operations for the first quarter ended March 31, 2016 was $1.36 million, compared to an operating loss from continuing operations of $3.82 million for the same quarter ended March 31, 2015. Net loss from continuing operations for the first quarter ended March 31, 2016 was $2.69 million, compared to a net loss from continuing operations of $297,000, for the same quarter ended March 31, 2015.